RCUS CIK: 1724521

Arcus Biosciences, Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25

Assets

(positive)
Change from FY21 to FY25
billions USD
FY21:
1.26
FY22:
1.07
FY23:
0.83
FY24:
1.02
FY25:
1.01
(positive)
Change from FY21 to FY25
billions USD
FY21:
0.33
FY22:
0.28
FY23:
0.26
FY24:
0.13
FY25:
0.13
Total assets
Change from FY21 to FY25
billions USD
FY21:
1.59
FY22:
1.35
FY23:
1.10
FY24:
1.15
FY25:
1.14

Liabilities & Equity

(negative)
Change from FY21 to FY25
billions USD
FY21:
0.17
FY22:
0.19
FY23:
0.18
FY24:
0.23
FY25:
0.23
(negative)
Change from FY21 to FY25
billions USD
FY21:
0.58
FY22:
0.50
FY23:
0.45
FY24:
0.44
FY25:
0.28
(positive)
Change from FY21 to FY25
billions USD
FY21:
0.84
FY22:
0.66
FY23:
0.46
FY24:
0.49
FY25:
0.63
Total liabilities & equity
Change from FY21 to FY25
billions USD
FY21:
1.59
FY22:
1.35
FY23:
1.10
FY24:
1.15
FY25:
1.14

All amounts in billions USD Data sources:SEC EDGARTwelve Data